Skip to main content

2026 Symposium

The Vascular Access Society of the Americas invites you to participate as an exhibitor at the 2026 Vascular Access for Dialysis Symposium, May 20-22, 2026 at the Hilton Salt Lake City Center in Salt Lake City, Utah.

This Symposium is designed for all transplant, vascular and general surgeons, nephrologists, interventional radiologists and nephrologists, nurses and allied health professionals who are interested in the management of vascular access. The VASA Symposium is an excellent opportunity for your company to showcase its products and services to a multidisciplinary audience committed to advancing dialysis patient care.

The Program Committee is busy planning an excellent scientific meeting that will include:

  • State-of-the-art lectures covering all major areas in dialysis access
  • Diverse multi-disciplinary faculty including prominent international
  • speakers representing Europe, Asia, Canada, South America, & Japan
  • 40 scientific abstract presentations
  • Vascular access nursing and allied health
  • New devices and technologies
  • Video presentations

Now accepting Abstracts

Interested in presenting? Submit an Abstract!

Thank You 2026 Symposium Sponsors

Gore
Platinum Sponsor
BD
Gold Sponsor
Laminate Medical Technologies
Gold Sponsor
Xeltis
Silver Sponsor

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Vascular Access Society of the Americas. Amedco LLC is jointly accredited by the AccreditationCouncil for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education forthe healthcare team.

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Physicians
Amedco LLC designates this live activity for a maximum of 19.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
Amedco LLC designates this activity for a maximum of 19.00 ANCC contact hours.

WEDNESDAY, MAY 20, 2026

07:00 AM - 08:00 AM

Breakfast

ALLIED HEALTH

08:00 AM - 08:05 AM

Welcome

08:05 AM - 08:20 AM

ESKD Life Plan and Access Plan

08:20 AM - 08:50 AM

AV Access Creation, HD Catheter and PD Placement

08:50 AM - 09:35 AM

Patient Models at Stations: 1-min Check with Patients, Physical Exams

09:35 AM - 09:55 AM

Break

09:55 AM - 10:25 AM

VASA Toolkit for Show & Tell

10:25 AM - 10:55 AM

Cannulation Stations

10:55 AM - 11:40 AM

ANNA Intermountain Chapter Collboration Session: 360 degree Care of the Nephrology Patient

11:40 AM - 12:05 PM

The Holland Keynote Lecture

12:05 PM - 01:05 PM

Lunch

CANNULATION

01:05 PM - 01:13 PM

Plastic Cannulas for HD Cannulation

01:13 PM - 01:21 PM

Eradicating Area Cannulation / Dead Space Between Dialysis Needles

01:21 PM - 01:29 PM

Covered Stent Grafts in Cannulation Segment

01:29 PM - 01:37 PM

Image Guided Access Cannulation

01:37 PM - 01:45 PM

Buttonhole Cannulation

01:45 PM - 01:53 PM

Self Cannulation

01:53 PM - 02:13 PM

Cannulation Issues and Solutions: Americas and Beyond

02:13 PM - 02:33 PM

Break

USRDS

02:33 PM - 02:45 PM

Welcome

02:45 PM - 02:57 PM

Fresenius or Davita: a Response

02:57 PM - 03:09 PM

How Can We Get Nephrologists to Refer Patients for Access Earlier?

03:09 PM - 03:21 PM

Artificial Intelligence will Save the Day (or Not)

03:21 PM - 03:33 PM

IPRO: IS CMS Oversight Effective?

03:33 PM - 03:45 PM

Not a One-and-Done: Role of Surgeons in Longitudinal Access Surveillance and Maintenance

03:45 PM - 03:55 PM

Break

ACCESS PARADIGM

03:55 PM - 04:07 PM

Centralization of HD Access Care to Specialized Centers

04:07 PM - 04:22 PM

DEBATE: OBL Vascular Access Centers vs Hospitals: The Good and the Bad

Speaker: Stephen Hohmann, MD; John Ross, MD

04:27 PM - 04:39 PM

Shared Decision Making - How?

04:39 PM - 04:51 PM

Home Hemodialysis

04:51 PM - 05:11 PM

Keynote Lecture - Current Status of Swine Renal Xenotransplantation

THURSDAY, MAY 21, 2026

07:00 AM - 08:00 AM

Breakfast

08:00 AM - 08:05 AM

Opening Remarks

08:05 AM - 08:25 AM

VASA Presidential Address

AUTOGENOUS AV FISTULA

08:25 AM - 08:37 AM

 Vein Mapping: Ultrasound vs Venography

The presentation will outline the key features of two techniques—ultrasound and venography—used to evaluate a patient’s vessels prior to vascular access creation. It will compare the advantages and limitations of each method and propose a recommended best-practice assessment pathway.

Learning Objectives

  • At the conclusion of this session, participants will be able to understand the difference between two different techniques for vein mapping before arteriovenous fistula creation and will be able to select the most appropriate one based on patient specific factos
Speaker: Adina Voiculescu, MD

08:37 AM - 08:49 AM

Which AVF is Best?

Speaker: Mohamad Hussain, MD, PhD

08:49 AM - 09:01 AM

Criteria and Predictors for Maturation

09:01 AM - 09:13 AM

The Immature AVF: Methods to Induce Maturation

09:13 AM - 09:25 AM

Endo AVF's - The Current Evidence and Role

09:25 AM - 09:45 AM

Debate: EndoAVF is Done vs Surgical Access Deserts

09:45 AM - 10:05 AM

Break

AV GRAFT

10:05 AM - 10:17 AM

AV Graft Materials and Configurations

Speaker: Jeffrey Lawson, MD, PhD

10:17 AM - 10:29 AM

HeRO Graft - Pros and Cons

10:29 AM - 10:35 AM

 M&M Case

Potential pitfalls of AV grafts.

Speaker: Tristen Chun, MD

10:35 AM - 10:41 AM

M&M Case

MANAGEMENT OF ACCESS COMPLICATIONS

10:41 AM - 10:53 AM

Management of HAIDI: Which Therapy in Which Stage?

10:53 AM - 11:05 AM

Preventing HAIDI (Hemodialysis Access Induced Distal Ischemia)

11:05 AM - 11:25 AM

Break

11:25 AM - 11:37 AM

High Flow Access Management: Surgical

Speaker: John Ross, MD

11:37 AM - 11:49 AM

High Flow Access Management: Endovascular

11:49 AM - 12:01 PM

Surgical and Endovascular Managemet of Aneurysms in AVF's

12:01 PM - 12:13 PM

AV Graft Pseudoaneurysms Treatment Options

12:13 PM - 12:43 PM

The Henry Keynote Lecture

12:43 PM - 01:43 PM

Lunch

AV ACCESS MAINTENANCE

01:43 PM - 01:55 PM

Access Surveillance - Optimal Methods

01:55 PM - 02:07 PM

Biology of Intimal Hyperplasia and Strategies for Prevention

02:07 PM - 02:19 PM

Covered Stents at the Venous Anastomosis: First Line or Last Line?

Speaker: Dheeraj Rajan, MD, FRCPC, FSIR, FACR

02:19 PM - 02:31 PM

Drug-Coated Balloons - Most Recent Data

02:31 PM - 02:43 PM

 Central Venous Stenosis - When to Treat and How?

Update presentation on the best practices to treat central venous stenosis.

Learning Objectives

  • Discuss indications, devices, technical details
  • Discuss how to avoid complications
Speaker: Marcelo Guimaraes, MD, MBA, CPE, FSIR

02:43 PM - 02:55 PM

 Bare vs Covered Stents for Central Veins: What to Use?

A review of when to use bare stents, and when to use covered stents for Thoracic Central Vein Obstruction (TCVO) in dialysis patients.

Learning Objectives

  • Recognize the limited use of bare stents in the thoracic central veins
  • Understand the potential for using covered stents in the thoracic central veins
Speaker: Bart Dolmatch, MD, FSIR

02:55 PM - 03:15 PM

Debate: Venous Anastomosis Stenosis: POBA, DCB, Stent, Stent Graft, Revise?

03:15 PM - 03:35 PM

Break

03:35 PM - 03:47 PM

Stent Venous Anastomosis - Consult with Vascular Surgeon or Just Do It?

03:47 PM - 03:59 PM

Stent vs HeRO for Arm Swelling Due to Central Stenosis

03:59 PM - 04:05 PM

Declotting AV Grafts: How I Do It (Vascular Surgeon)

04:05 PM - 04:11 PM

Declotting AV Grafts: How I Do It (Interventional Nephrologist)

04:11 PM - 04:17 PM

Declotting AV Grafts: How I Do It (Interventional Radiologist)

04:17 PM - 04:29 PM

Impact of Hypotension on AV Access

04:29 PM - 04:41 PM

Post Transplant Access Management: Keep or Ligate?

04:41 PM - 05:01 PM

Break

NEW TECHNOLOGY

05:01 PM - 05:07 PM

Xeltis

05:07 PM - 05:13 PM

New Technology 2

05:13 PM - 05:19 PM

New Technology 3

05:19 PM - 05:25 PM

New Technology 4

05:25 PM - 05:31 PM

New Technology 5

05:31 PM - 05:37 PM

New Technology 6

FRIDAY, MAY 22, 2026

07:00 AM - 08:00 AM

Breakfast

PERITONEAL DIALYSIS

08:00 AM - 08:12 AM

Patient Considerations for PD: Pros and Cons vs HD

08:12 AM - 08:18 AM

How I Do It : PD Catheter Insertion (Surgery)

08:18 AM - 08:24 AM

How I Do It : PD Catheter Insertion (Interventional Nephrology)

08:24 AM - 08:30 AM

How I Do It : PD Catheter Insertion (Interventional Radiology)

08:30 AM - 08:50 AM

Debate: Who Should be First Line for PD Catheter Insertion?

08:50 AM - 09:02 AM

 Management of PD Catheter Dysfunction

Peritoneal dialysis (PD) catheter dysfunction remains a primary driver of technique failure. This session explores the clinical complexities of catheter dysfunction. Participants will evaluate a staged management algorithm, beginning with conservative medical therapies and advancing to more invasive therapies including fluoroscopic catheter wire manipulation, catheter reposition and catheter exchange.

Learning Objectives

  • Understand the different etiologies of catheter dysfunction and how they may present
  • Be familiar with different strategies of catheter salvage
Speaker: David Strain, MD

09:02 AM - 09:22 AM

Debate: Fistula First or PD Catheter First?

09:22 AM - 09:42 AM

Break

HEMODIALYSIS CVC's

09:42 AM - 09:54 AM

Femoral TDC's: Always Bad?

09:54 AM - 10:06 AM

When the IJ's are Gone: Where to Go?

10:06 AM - 10:18 AM

Catheter Locks, Dressings, and Coatings: What Works?

10:18 AM - 10:30 AM

 Avoiding IV's and PICC Lines in CKD Patients: HOW??

To improve long-term outcomes for patients with Chronic Kidney Disease (CKD), we must implement a strict vein preservation protocol. This policy mandates a formal consultation with a vascular access team before any central or peripheral access is placed in patients with CKD stage 3-5. by requiring consultation this team can evaluate these patients and identify the most appropriate access for this patient.

Learning Objectives

  • Identify the risks of central vein stenosis and vessel depletion associated with non-indicated vascular access in the CKD population
  • Evaluate institutional strategies and policy-driven interventions designed to limit peripherally inserted access and prioritize vein preservation in CKD patients
Speaker: David Strain, MD

MISC AV ACCESS TOPICS

10:30 AM - 10:42 AM

Myth or Reality: Axillary Lymph Node Dissections - Impactful on Access?

10:42 AM - 10:54 AM

Nerve Blocks for Access Creation and Maintenance

10:54 AM - 11:06 AM

Blood Pump Speed and Fistula/Graft Survival

11:06 AM - 11:18 AM

AI and Robotics in Dialysis Vascular Access: Future is Now

11:18 AM - 11:30 AM

Frailty and Multi-Morbidity

11:30 AM - 11:42 AM

ESKD Life Plan and Access Plan: Surgery Perspective vs Practice Bldg

11:42 AM - 11:54 AM

Access for Morbid Obesity

11:54 AM - 12:06 PM

Flow Volume Measurements

12:06 PM - 12:18 PM

TBD

12:18 PM - 12:30 PM

TBD

12:30 PM - 01:30 PM

Lunch

TOP ABSTRACTS

01:30 PM - 01:38 PM

Abstract 1

01:38 PM - 01:46 PM

Abstract 2

01:46 PM - 01:54 PM

Abstract 3

01:54 PM - 02:02 PM

Abstract 4

02:02 PM - 02:10 PM

Abstract 5

INTERNATIONAL FORUM

02:10 PM - 03:25 PM

Dialysis Controversies Across the Continents

03:25 PM - 03:30 PM

Closing Remarks